scispace - formally typeset
V

Veronica Catalano

Researcher at University of Palermo

Publications -  12
Citations -  1262

Veronica Catalano is an academic researcher from University of Palermo. The author has contributed to research in topics: Cancer stem cell & Cancer. The author has an hindex of 9, co-authored 12 publications receiving 1045 citations.

Papers
More filters
Journal ArticleDOI

CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis

TL;DR: It is shown that all colorectal cancer stem cells (CR-CSCs) express CD44v6, which is required for their migration and generation of metastatic tumors, and phosphatidylinositol 3-kinase (PI3K) inhibition selectively killed CD 44v6 CR-C SCs and reduced metastatic growth.
Journal ArticleDOI

Tumor and its microenvironment: A synergistic interplay

TL;DR: The synergistic effect of hypoxia inducible factors (HIFs) and vascular endothelial growth factors (VEGFs) in the successful outgrowth of metastasis is focused on, integrating therefore many of the emerging models and theories in the field.
Journal ArticleDOI

Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.

TL;DR: Study of features of γδ T cells in colorectal cancer, normal colon tissue and peripheral blood, and correlated their levels with clinicopathologic hallmarks revealed their efficacy in controlling tumor at very early stage.
Journal ArticleDOI

Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling

TL;DR: It is found that increased intracellular thyroid hormone concentration through D3 depletion induced cell differentiation and sharply mitigated tumor formation, and it is demonstrated that BMP4 is a direct thyroid hormone target and is involved in a positive autoregulatory feedback loop that modulates thyroid hormone signaling.
Journal ArticleDOI

Therapeutic implications of Cancer Initiating Cells.

TL;DR: Current cancer treatments, based on the assumption that tumour cell population responds homogeneously, have been developed to eradicate proliferating cells, but the new model of tumorigenesis entails significant therapeutic implications, in fact if a small fraction of CICs survives conventional therapy it may lead to recurrence after month or years of apparent remission.